Four-Membered Ring-Containing Spirocycles: Synthetic Strategies and Opportunities

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139

Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success

Lovering, F., Bikker, J., & Humblet, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901241e · Cited by 4,495

Function-Oriented Synthesis, Step Economy, and Drug Design

Wender, P. A., Verma, V. A., Paxton, T. J., & Pillow, T. H. (2008) · Accounts of Chemical Research · doi:10.1021/ar700155p · Cited by 1,204

A Simple, Mild, Catalytic, Enantioselective Addition of Terminal Acetylenes to Aldehydes

Anand, N. K., & Carreira, E. M. (2001) · Journal of the American Chemical Society · doi:10.1021/ja016378u · Cited by 473

Oxetanes as Versatile Elements in Drug Discovery and Synthesis

Burkhard, J. A., Wuitschik, G., Rogers‐Evans, M., Müller, K., & Carreira, E. M. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200907155 · Cited by 441

Oxetanes in Drug Discovery: Structural and Synthetic Insights

Wuitschik, G., Carreira, E. M., Wagner, B., Fischer, H., Parrilla, I., Schuler, F., Rogers-Evans, M., & Müller, K. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm9018788 · Cited by 418

Heterocyclic Chemistry in Drug Discovery

Li, J. J. (2013) · Cited by 325

Enantioselective Intramolecular [2 + 2]-Photocycloaddition Reactions of 4-Substituted Quinolones Catalyzed by a Chiral Sensitizer with a Hydrogen-Bonding Motif

Müller, C., Bauer, A., Maturi, M. M., Cuquerella, M. C., Miranda, M. A., & Bach, T. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207480q · Cited by 235

Total Synthesis of (+)‐Daphmanidin E

Weiss, M. E., & Carreira, E. M. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201104681 · Cited by 187

Immunizations and Autism: A Review of the Literature

Doja, A., & Roberts, W. (2006) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s031716710000528x · Cited by 123

Expanding the Azaspiro[3.3]heptane Family: Synthesis of Novel Highly Functionalized Building Blocks

Burkhard, J. A., Guerot, C. M., Knust, H., & Carreira, E. M. (2011) · Organic Letters · doi:10.1021/ol2028459 · Cited by 110

Orally Active .beta.-Lactam Inhibitors of Human Leukocyte Elastase. 3. Stereospecific Synthesis and Structure-Activity Relationships for 3,3-Dialkylazetidin-2-ones

Finke, P. E., Shah, S. K., Fletcher, D. S., et al. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00013a021 · Cited by 89

Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles

Wang, Y., Liu, J., Dransfield, P. J., Zhu, L., Wang, Z., Du, X., Jiao, X., Su, Y., Li, A., Brown, S. P., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300427u · Cited by 87

Synthesis and Stability of Oxetane Analogs of Thalidomide and Lenalidomide

Burkhard, J. A., Wuitschik, G., Plancher, J., Rogers‐Evans, M., & Carreira, E. M. (2013) · Organic Letters · doi:10.1021/ol401705a · Cited by 83

New progesterone receptor antagonists: 3,3-disubstituted-5-aryloxindoles

Fensome, A., Bender, R. H. W., Cohen, J. D., Collins, M. A., Mackner, V. A., Miller, L. L., Ullrich, J. W., Winneker, R. C., Wrobel, J. E., Zhang, P., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00746-1 · Cited by 75

Diversity‐Oriented Preparation of Enantiopure Spirocyclic 2‐Azetidinones from α‐Oxo‐β‐lactams through Barbier‐Type Reactions followed by Metal‐Catalyzed Cyclizations

Alcaide, B., Almendros, P., del Campo, T. M., & Rodríguez‐Acebes, R. (2007) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.200600502 · Cited by 63

Pyrazinoindolone inhibitors of MAPKAP-K2

Goldberg, D. R., Choi, Y.-C., Cogan, D. A., Corson, M. H., DeLeon, R. P., Gao, A., Gruenbaum, L. M., Hao, M., Joseph, D. P., Kashem, M. A., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.12.037 · Cited by 55

Radical-mediated reduction of the dithiocarbamate group under tin-free conditions

McMaster, C., Bream, R. N., & Grainger, R. S. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob25434d · Cited by 51

Discovery and in Vivo Evaluation of Dual PI3Kβ/δ Inhibitors

de Turiso, F. G.-L., Shin, Y., Brown, M. F., Cardozo, M. G., Chen, Y., Fong, D., Hao, X., He, X., Henne, K. R., Hu, Y., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300679u · Cited by 50

Titanocene catalyzed opening of oxetanes

Gansäuer, A., Schiffer-Ndene, N., Lauterbach, T., Justicia, J., Winkler, I., Mück‐Lichtenfeld, C., & Grimme, S. (2008) · Tetrahedron · doi:10.1016/j.tet.2008.08.107 · Cited by 50

Design and Synthesis of Potent, Orally Efficacious Hydroxyethylamine Derived β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors

Dineen, T. A., Weiss, M. M., Williamson, T. L., Acton, P., Babu‐Khan, S., Bartberger, M. D., Brown, J., Chen, K., Cheng, Y., Citron, M., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300118s · Cited by 43

Discovery of potent and efficacious urea-containing nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with reduced CYP2C9 inhibition properties

Gunzner, J. L., Zhao, G., Bauer, P., Baumeister, T., Buckmelter, A. J., Caligiuri, M., Clodfelter, K. H., Fu, B., Han, B., Ho, Y., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.04.040 · Cited by 42

Intramolecular Diels–Alder Reactions of Cycloalkenones: Translation of High Endo Selectivity to Trans Junctions

Ross, A. G., Li, X., & Danishefsky, S. J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja307708q · Cited by 40

Synthesis of Four Novel Natural Product Inspired Scaffolds for Drug Discovery

Jenkins, I. D., Lacrampe, F., Ripper, J. A., Alcaraz, L., Le, P. V., Nikolakopoulos, G., Leone, P. D. A., White, R. H., & Quinn, R. J. (2008) · The Journal of Organic Chemistry · doi:10.1021/jo802456w · Cited by 39

Synthesis of novel arylpyrazolo corticosteroids as potential ligands for imaging brain glucocorticoid receptors

Wüst, F. R., Carlson, K. E., & Katzenellenbogen, J. A. (2003) · Steroids · doi:10.1016/s0039-128x(02)00171-x · Cited by 39

A Rapid, One-Pot, Microwave-Influenced Synthesis of Spiro-2,5-diketopiperazines via a Cascade Ugi/6-Exo-Trig Aza-Michael Reaction

Santra, S., & Andreana, P. R. (2011) · The Journal of Organic Chemistry · doi:10.1021/jo102305q · Cited by 36

In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part II

Révész, L., Schlapbach, A., Aichholz, R., Dawson, J., Feifel, R., Hawtin, S. R., Littlewood-Evans, A. J., Koch, G., Kroemer, M., Möbitz, H., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.023 · Cited by 33

Indolin-2-one p38α inhibitors I: Design, profiling and crystallographic binding mode

Eastwood, P. R., González, J., Gómez, E., Vidal, B., Caturla, F., Roca, R., Balagué, C., Orellana, A., & Domínguez, M. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.05.114 · Cited by 30

In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part I

Révész, L., Schlapbach, A., Aichholz, R., Feifel, R., Hawtin, S. R., Heng, R., HIESTAND, P. C., Jahnke, W., Koch, G., Kroemer, M., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.024 · Cited by 30

Metal‐Catalyzed Cycloisomerization and Tandem Oxycyclization/Hydroxylation of Alkynols: Synthesis of Nonfused, Spiranic and Fused Oxabicyclic β‐Lactams

Alcaide, B., Almendros, P., del Campo, T. M., & Carrascosa, R. (2010) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201000710 · Cited by 29

Design and synthesis of highly selective, orally active Polo-like kinase-2 (Plk-2) inhibitors

Bowers, S., Truong, A. P., Ye, M., Aubele, D. L., Sealy, J. M., Neitz, R. J., Hom, R. K., Chan, W., Dappen, M. S., Galemmo, R. A., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.02.065 · Cited by 28

Syntheses of C-5-spirocyclic C-glycoside SGLT2 inhibitors

Mascitti, V., Robinson, R. P., Préville, C., Thuma, B. A., Carr, C. L., Reese, M. R., Maguire, R. J., Leininger, M. T., Lowe, A., & Steppan, C. M. (2010) · Tetrahedron Letters · doi:10.1016/j.tetlet.2010.02.024 · Cited by 21

Stereoselective synthesis of spiro-β-lactams using d-(+)-glucose derived chiral pool: remarkable influence of the torquoelectronic effect

Chincholkar, P. M., Puranik, V. G., & Deshmukh, A. R. A. S. (2007) · Tetrahedron · doi:10.1016/j.tet.2007.06.073 · Cited by 20

Chromanol derivatives—A novel class of CETP inhibitors

Vakalopoulos, A., Schmeck, C., Thutewohl, M., Li, V., Bischoff, H., Lustig, K., Weber, O., Paulsen, H., & Elias, H. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.10.110 · Cited by 20

Quick Access to Diverse Polymerizable Molecules (a Monomer Library) by Catalytic [2 + 2 + 2] Cycloaddition Reactions of Functionalized Alkynes

Watanabe, J., Sugiyama, Y., Nomura, A., Azumatei, S., Goswami, A., Saino, N., & Okamoto, S. (2010) · Macromolecules · doi:10.1021/ma902792a · Cited by 18

Structure guided P1′ modifications of HEA derived β-secretase inhibitors for the treatment of Alzheimer’s disease

Monenschein, H., Horne, D. B., Bartberger, M. D., Hitchcock, S. A., Nguyen, T. T. H., Patel, V. F., Pennington, L. D., & Zhong, W. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.04.060 · Cited by 13

New synthesis of multi-substituted α-chlorocyclobutanones from 1-chloro-3-cyanoalkyl p-tolyl sulfoxides by 4-Exo-Dig nucleophilic ring closure of magnesium carbenoids to nitrile group as the key reaction

Saitoh, H., Sampei, T., Kimura, T., Kato, Y., Ishida, N., & Satoh, T. (2012) · Tetrahedron Letters · doi:10.1016/j.tetlet.2012.03.127 · Cited by 9

Catalytic Enantioselective Construction of Spiro Quaternary Carbon Stereocenters

Xu, P.-W., Yu, J.-S., Chen, C., Cao, Z.-Y., Zhou, F., & Zhou, J. (2019) · ACS Catalysis · doi:10.1021/acscatal.8b03694 · Cited by 325

The utilization of spirocyclic scaffolds in novel drug discovery

Zheng, Y.-J., & Tice, C. M. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1195367 · Cited by 299